Literature DB >> 2707059

Bronchoscopy in the diagnosis of pulmonary histoplasmosis.

G C Prechter1, U B Prakash.   

Abstract

Although histoplasmosis is the most common fungal infection of the lungs in the United States, there are no reports evaluating the efficacy of fiberoptic bronchoscopy in the diagnosis of this disease. We reviewed all cases of histoplasmosis diagnosed at our institution from 1972 to 1987. Of 469 patients, 71 underwent fiberoptic bronchoscopy and had culture/histologic proof of histoplasmosis established by fiberoptic bronchoscopy or other means. A diagnosis of pulmonary histoplasmosis could be made without thoracotomy in only 27. Among those not requiring thoracotomy, diagnosis of pulmonary histoplasmosis was confirmed by fiberoptic bronchoscopy and cultures of sputum, gastric washings, blood, bone marrow, and urine. In this subgroup, fiberoptic bronchoscopy was the only positive diagnostic method in eight of 27 patients. We conclude that fiberoptic bronchoscopy is a useful adjunct to other noninvasive measures yielding diagnostic material in most cases, except for solitary pulmonary nodule where it is rarely helpful.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2707059     DOI: 10.1378/chest.95.5.1033

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  3 in total

Review 1.  Bronchoscopic diagnosis of pneumonia.

Authors:  V S Baselski; R G Wunderink
Journal:  Clin Microbiol Rev       Date:  1994-10       Impact factor: 26.132

2.  Bronchoscopic findings in a case of bronchopulmonary histoplasmosis.

Authors:  B Kneale; C Turton
Journal:  Thorax       Date:  1995-03       Impact factor: 9.139

Review 3.  Disseminated Histoplasmosis as AIDS-presentation. Case Report and Comprehensive Review of Current Literature.

Authors:  Paola Zanotti; Claudia Chirico; Maurizio Gulletta; Laura Ardighieri; Salvatore Casari; Eugenia Quiros Roldan; Ilaria Izzo; Gabriele Pinsi; Giovanni Lorenzin; Fabio Facchetti; Francesco Castelli; Emanuele Focà
Journal:  Mediterr J Hematol Infect Dis       Date:  2018-07-01       Impact factor: 2.576

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.